Ethyl (S)-1,2,3,4-tetrahydroisoquinoline-3-carboxylate hydrochloride, 95%, 5g

4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)butanoic acid hydrochloride, 95+%, 5g

tert-Butyl (10-bromodecyl)carbamate, 95%, 500mg

Endo-M-W251N Recombinant: from Mucor hiemalis expressed in Escherichia coli (500m units/vial)1vial

(2E)-3-(2,3-Dihydrobenzofuran-5-yl)propenoic acid, 95.0%, 10g

2-{3-oxo-2h,3h-[1,2,4]triazolo[4,3-a]pyridin-2-yl}acetonitrile, 95%, 500mg

4-Amino-N'-hydroxybenzimidamide, 97%, 5g

4-Amino-6-chloro-5-fluoropyrimidine, 95.0%, 1g

4,5-Difluoro-2-methoxybenzonitrile, 97.0%, 1g

1-BOC-3-METHYLPIPERIDINE-4-CARBOXYLIC ACID METHYL ESTER, 95.0%, 250mg

(2,6-Dimethylpyridin-4-yl)methanol, 97.0%, 5g

Ethyl 5-chloro-2-(2-chloroacetamido)-4-phenylthiophene-3-carboxylate, 98%, 250mg

Cyclopropyl phenyl sulfide, 95.0%, 25g